Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James McKenney

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Archives of Internal Medicine|April 14, 2004
New perspectives on the use of niacin in the treatment of lipid disordersJames McKenney
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 7, 2003
Niacin for dyslipidemia: considerations in product selectionJames McKenney
Expert Review of Cardiovascular Therapy|September 27, 2005
Torcetrapib/atorvastatin combination therapyHarold Bays, James McKenney, Michael Davidson
Current Medical Research and Opinion|October 4, 2005
Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemiaJames McKenney, Michael Jones, Stacey Abby
Journal of Clinical Lipidology|February 5, 2011
Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoringJames McKenney, Sanjay K Gandhi, Kathleen M Fox, et al.
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Clinical Cardiology|September 5, 2015
Insights Into Statin IntoleranceStephen Kopecky, Seth Baum, JoAnne M Foody, et al.
Journal of Clinical Lipidology|June 16, 2015
Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trialsJames McKenney, Harold Bays, Gilbert Gleim, et al.
Obesity Research|July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trialJames W Anderson, Frank L Greenway, Ken Fujioka, et al.
Mayo Clinic Proceedings|February 2, 2010
Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatinHarold E Bays, James McKenney, Kevin C Maki, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Archives of Internal Medicine|April 14, 2004
New perspectives on the use of niacin in the treatment of lipid disordersJames McKenney
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 7, 2003
Niacin for dyslipidemia: considerations in product selectionJames McKenney
Expert Review of Cardiovascular Therapy|September 27, 2005
Torcetrapib/atorvastatin combination therapyHarold Bays, James McKenney, Michael Davidson
Current Medical Research and Opinion|October 4, 2005
Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemiaJames McKenney, Michael Jones, Stacey Abby
Journal of Clinical Lipidology|February 5, 2011
Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoringJames McKenney, Sanjay K Gandhi, Kathleen M Fox, et al.
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Clinical Cardiology|September 5, 2015
Insights Into Statin IntoleranceStephen Kopecky, Seth Baum, JoAnne M Foody, et al.
Journal of Clinical Lipidology|June 16, 2015
Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trialsJames McKenney, Harold Bays, Gilbert Gleim, et al.
Obesity Research|July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trialJames W Anderson, Frank L Greenway, Ken Fujioka, et al.
Mayo Clinic Proceedings|February 2, 2010
Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatinHarold E Bays, James McKenney, Kevin C Maki, et al.
Pageof 2